Endocyte could get $1B from Merck development deal - BusinessWeek
Links shared publicly online about this topic.
- 0total visits
Endocyte could get $1B from Merck development deal - BusinessWeek
Endocyte Inc. said Monday that Merck & Co. will help develop and market its experimental cancer drug vintafolide, and Endocyte could get more than $1 billion if the drug is successfully developed as a treatment for multiple types of cancer.
View full resource at businessweek.com
Most Recently Shared on April 16, 2012 at 8:46 pm By:
Merck to buy Endocyte cancer therapy for as much as $1B if tests are successful. http://t.co/cG7H3qTw
Advertisement
